Global prevalence of syphilis among men who have sex with men (MSM)
The World Health Organization Global Health Sector Strategy aims to reduce worldwide syphilis incidence by 90% between 2018 and 2030. To achieve this goal, interventions that target high-burden groups, including MSM, will be required. However, there are no global prevalence estimates of syphilis among MSM to serve as a baseline for monitoring or modelling disease burden.
To fill this evidence gap, we conducted a global systematic review and meta-analysis for syphilis prevalence among MSM between 2000 and 2020. Our findings presented unacceptably high global syphilis prevalence among MSM. Sustained commitment to interventions that can accelerate syphilis prevention, screening, and treatment in this population is urgently needed even in the COVID-19 pandemic.
Motoyuki Tsuboi is an infectious disease physician, currently based in National Center for Global Health and Medicine, Tokyo, Japan. He is a graduate of MSc Tropical Medicine and International Health at the London School of Hygiene & Tropical Medicine. His research focus is mainly on STI/HIVs, particularly for syphilis, and the epidemiology of various infectious diseases.
Please note that the session will not be recorded